S. Floquet

From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.

N. Desroy, F. Moreau, V. Gerusz, 2012, Journal of medicinal chemistry.

NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis

Carmen Buchrieser, Philippe Glaser, Christophe Rusniok, 2009, Genome Biology.

Systematic synthesis of inhibitors of the two first enzymes of the bacterial heptose biosynthetic pathway: towards antivirulence molecules targeting lipopolysaccharide biosynthesis.

M. Durka, F. Moreau, V. Gerusz, 2011, Chemistry.

Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.

N. Desroy, F. Moreau, V. Gerusz, 2008, Bioorganic & medicinal chemistry letters.

Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis.

X. Nassif, V. Pelicic, S. Floquet, 2003, Genome research.

The Superantigen Gene ypm Is Located in an Unstable Chromosomal Locus of Yersinia pseudotuberculosis

A. Devalckenaere, M. Simonet, M. Marceau, 2002, Journal of bacteriology.

Towards Gram-negative antivirulence drugs: new inhibitors of HldE kinase.

N. Desroy, F. Moreau, V. Gerusz, 2009, Bioorganic & medicinal chemistry.

Novel HldE-K inhibitors leading to attenuated Gram negative bacterial virulence.

M. Junop, N. Desroy, F. Moreau, 2013, Journal of medicinal chemistry.